Compositions and methods for determining the activity of DNA-binding proteins and of initiation of transcription

• US 6,265,213 B1
• Filed: 06/13/2000
• Issued: 07/24/2001
• Est. Priority Date: 06/24/1999
• Status: Expired due to Fees

• Current Assignee: DNA Diagnostics Incorporated
• Original Assignee: DNA Diagnostics Incorporated
• Inventors: Morgan, Antony R., Severini, Alberto
• Primary Examiner(s): Zitomer, Stephanie W.
• Assistant Examiner(s): WILDER, CYNTHIA B
• Application Number:
  US09/593,323
• Time in Patent Office: 406 Days
• Field of Search: 435/320.1, 435/478.8, 435/196, 435/199, 435/6, 530/350, 536/23.1
• US Class Current: 435/320.1
• CPC Class Codes: C12N 15/1034 Isolating an individual clone by screening libraries

Abstract

This invention provides plasmids that are useful in detecting and determining the DNA-binding activity of sequence-specific DNA-binding molecules. The invention further provides plasmids that are useful in detecting and determining the activity of RNA polymerases in initiating transcription. In particular, the invention relates to plasmids that contain unique restriction sites and cognate nucleotide recognition sequences for sequence-specific DNA-binding molecules. Also provided are methods for using the plasmids disclosed herein.

Claims

1. A recombinant plasmid comprising:

(a) a first region comprising a nucleotide sequence which specifically binds to a sequence-specific DNA-binding molecule;

(b) a second region comprising a nucleotide sequence which binds to a restriction enzyme; and

(c) a restriction site for said restriction enzyme;

wherein said restriction site is located at a position selected from being within said first nucleotide sequence, within said second nucleotide sequence, substantially adjacent to said first nucleotide sequence, and substantially adjacent to said second nucleotide sequence.

2. The recombinant plasmid of claim 1, wherein said restriction site is comprised within said first nucleotide sequence, and said plasmid is selected from pDNAB-NFκ

B, pDNAB-TATA and pDNABtac.

3. The recombinant plasmid of claim 1, wherein said restriction site is comprised within said second nucleotide sequence, and said plasmid is pDNAB-or1.

4. The recombinant plasmid of claim 1, wherein said restriction site is substantially adjacent to said first nucleotide sequence, and said plasmid is pDNAB-or1.

5. The recombinant plasmid of claim 1, wherein said restriction site is substantially adjacent to said second nucleotide sequence, and said plasmid is selected from pDNAB-NFκ

B, pDNAB-TATA and pDNABtac.

6. The recombinant plasmid of claim 1, wherein said restriction enzyme is selected from AatII, AccI, AflI, AflIII, AhaII, Alul, AIwI, AlwNI, ApaI, ApaLI, AseI, Asp718, AvaI, AvaII, AvrII, BalI, BamHI, BanI, BanII, BbeI, BbvI, BbvII, BcII, BcnI, BgII, BgIII, BseRIBsmI, BsmAI, Bsp1286I, BspHI, BspMI, BspMII, BsrI, BssHII, BstBI, BstEII, BstNI, BstUI, BstXI, BstYI, Bsu36I, Cfr10I, ClaI, DdeI, DpnI, DraI, DraIII, EaeI, EagI, EarI, Eco47III, EcoNI, EcoO109I, EcoRI, EcoRII, EcoRV, EspI, Fnu4HI, FokI, FspI, GdiII, HaeI, HaeII, HaeIII, HgaI, HgiAI, HihaI, HinCII, HinIII, HinfI, HinPI, HpaI, HpaII, HphI, KpnI, MaeI, MaeII, MaeIII, MboI, MboII, MluI, MnII, MseI, MspI, NaeI, NarI, NciI, NcoI, NdeI, NheI, NlaIII, NIaIV, NotI, NruI, NsiI, Nsp7524I, NspBII, NspHI, PaeR7I, PflMI, PleI, PpuMI, PstI, PvuI, PvuII, RsaI, RsrII, SacI, SacII, SaII, Sau3AI, Sau96I, ScaI, ScrFI, SecI, SfaNI, SfiI, SmaI, SnaBI, SpeI, SphI, SplI, SspI, StuI, StyI, TaqI, Tth111I, Tth111II, XbaI, XcaI, XhoI, XmaI, XmnI.

7. The recombinant plasmid of claim 1, wherein said sequence-specific DNA-binding molecule is selected from nucleic acid sequence, amino acid sequence, derivative of nucleic acid sequence and derivative of amino acid sequence.

8. The recombinant plasmid of claim 7, wherein said sequence-specific DNA-binding molecule is a protein selected from λ

cI repressor, TATA box binding protein, NFκ

B, bacterial mercury repressor, bacterial lac repressor, progesterone repressor, estrogen receptor, glucocorticoid receptor, androgen receptor, retinoid receptor family, thyroid receptor, p53, lac suppressor, AraC, DnaA, MerR, HSV-1 ICP4, UL9, c-Myc/c-Max, RecBCD, γ

/δ

resolvase, λ

bacteriophage integrase complex, DNA photolyase, Ada protein, methylated Ada protein, Rag1/Rag2, bacterial RNA polymerase, c-Jun, AP2, SP1, TFIIB, vitamin D receptor, AP-1 complex, Sp1, CREB family, C/EBP family, Egr family, Ets family, Stat family, NF-1 family, YY1, Ap-2 factors, E2F family, IRF family, MEF-2, Myo-D/Myo-E, Oct family, Pit-1, USF-1/USF-2, c-Myb, Pbx-1, GATA family, NF-E2, serum response factor, T7 bacteriophage RNA polymerase, T3 bacteriophage RNA polymerase, SP6 bacteriophage RNA polymerase, eukaryotic RNA polymerase I, eukaryotic RNA polymerase II, eukaryotic RNA polymerase III, PBS1 phage RNA polymerase, PBS2 phage RNA polymerase, vaccinia virus RNA polymerase, Escherichia coli RNA polymerase, and mitochondrion RNA polymerase.